Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
The Journal of Clinical Investigation
|
October 12, 2018
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei, Anantha Marisetty, Brett Schrand, et al.
Leukemia
|
October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
Elspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Journal of Participatory Medicine
|
August 21, 2025
Engagement Methods in Brain Tumor Genomic Research: Multimethod Comparative Study
Matthew DeCamp, Juliana G Barnard, Carly Ritger, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Neuro-Oncology Advances
|
January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram
Sherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.
JCI Insight
|
March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
Hinda Najem, Martina Ott, Cynthia Kassab, et al.
BMJ Open
|
May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study
Benjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 15, 2025
Optimizing participant and community engagement in cancer genomic sequencing research
Norah L Crossnohere, Anne L R Schuster, Cindy K Blair, et al.
BMJ Open
|
August 4, 2023
[<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
Eng-Siew Koh, Hui K Gan, Clare Senko, et al.
Nature Communications
|
June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
Ravi S Narayan, Piet Molenaar, Jian Teng, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
The Journal of Clinical Investigation
|
October 12, 2018
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei, Anantha Marisetty, Brett Schrand, et al.
Leukemia
|
October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions
Elspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Journal of Participatory Medicine
|
August 21, 2025
Engagement Methods in Brain Tumor Genomic Research: Multimethod Comparative Study
Matthew DeCamp, Juliana G Barnard, Carly Ritger, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Neuro-Oncology Advances
|
January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram
Sherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.
JCI Insight
|
March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
Hinda Najem, Martina Ott, Cynthia Kassab, et al.
BMJ Open
|
May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study
Benjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 15, 2025
Optimizing participant and community engagement in cancer genomic sequencing research
Norah L Crossnohere, Anne L R Schuster, Cindy K Blair, et al.
BMJ Open
|
August 4, 2023
[<sup>18</sup>F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
Eng-Siew Koh, Hui K Gan, Clare Senko, et al.
Nature Communications
|
June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
Ravi S Narayan, Piet Molenaar, Jian Teng, et al.
Page
of 3